UK Drug Regulators Approve Botox for Migraine Treatment

by Kathy Jones on  July 10, 2010 at 11:01 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The Medicines and Healthcare Products Regulatory Agency has approved the use of botox for the treatment of chronic migraine.
 UK Drug Regulators Approve Botox for Migraine Treatment
UK Drug Regulators Approve Botox for Migraine Treatment

The approval follows a study involving 1,300 people, which showed that botox reduced the frequency of headaches. The regulator said that the approval was only for people who suffered headaches 15 days a month.

"We have been following these studies really closely and the evidence is really pretty solid," said Lee Tomkins, director of Migraine Action. "These people spend half their lives in pain. Even if they get half the attacks, it can really improve their quality of life."

Estimates indicate that 700,000 people in the UK get chronic migraines. Botx injections are usually used to smooth wrinkles, but they have also shown efficacy in reducing frequency of headaches in migraines.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Migraine Botox Signature Drug Toxicity Headache / Cephalgia Face Lift (Rhytidectomy) Anti-aging Secrets to a Younger You Cosmetic Surgery and the Risk Factors Headache Symptom Evaluation Wrinkles and Anti-Wrinkle Treatments 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...